POSTER COMMUNICATIONS
1986; Wiley; Volume: 87; Issue: S1 Linguagem: Inglês
10.1111/j.1476-5381.1986.tb14741.x
ISSN1476-5381
Tópico(s)Neuropeptides and Animal Physiology
ResumoBritish Journal of PharmacologyVolume 87, Issue S1 p. 95P-224P Free Access POSTER COMMUNICATIONS First published: March 1986 https://doi.org/10.1111/j.1476-5381.1986.tb14741.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References Towart R. (1985) In: Control and manipulation of calcium movement, Ed. J.R. Parratt, pp 169– 187, Raven Press, New York. Schramm M., Thomas G., Towart R. and Frankowiack G. (1983) Nature, 303, 535– 537. Van Zwieten P.A. (1985) Arzneim-Forsch./Drug Res., 35(I), 298– 300. Armstrong J.M. and Ferrandon P. (1985) Br. J. Pharmacol., 85, 328P. References Preuss et al., J Cardiovasc Pharmacol, Vol. 6, No. 5, 1984, 949– 953. Schramm et al., Nature, Vol. 309, 1983, 535– 537. References Clarke, B. et al (1983) Br. J. Pharmac., 79, 333P. Eglen, R.M. et al (1983) Br. J. Pharmac., 80, 556P. Langs, D.A. & Triggle, D.J. (1985) Mol. Pharmacol., 27, 544. Schramm, M. et al (1983) Arzneim. Forsch./Drug Res., 33, 1268. Takenaka, T. & Maeno, H. (1982) Jap. J. Pharmacol., 32, (suppl.) 139P. References Clarke, B. et al (1984) Br. J. Pharmac., 83, 365P. Langs, D.A. & Triggle, D.J. (1985) Mol. Pharmacol., 27, 544. Spedding, M. & Berg, C. (1984) Naunyn-Schmiederberg's Arch. Pharmacol., 328, 69. Triggle, D.J. & Janis, R.A. (1984) J. Cardiovasc. Pharmacol., 6, S949. References Gurney, A. M. et al. (1985). J. Gen. Physiol. 86, 353– 379. Hamill, O. P. et al. (1981). Pflugers Arch. 391, 85– 100. Hille, B. (1977) J. Gen. Physiol. 69, 497– 515. Lee, K. S. & Tsien, R. W. (1983) Nature 302, 790– 794. References Hille B. (1984) Ionic Channels of Excitable Membranes. Sinauer, Sunderland, Mass. Romey G. & Lazdunski M. (1982) Nature, 297, 79– 81. Spedding M. (1985) Trends Pharmac. Sci, 6, 109– 114. Spedding M. & Berg C. (1984) Naunyn-Schmiedeberg's Arch. Pharmacol., 328, 69– 75. Spedding M. & Berg C. (1985) Eur. J. Pharmac., 108, 143– 150. Strichartz G.R. (1973) J. Gen. Physiol., 62, 37– 57. References Herzig et al., Arzneim. Forsch. 31, 188– 191 (1981). Solaro and Rüegg, Circ. Res. 51, 290– 294 (1982). Rüegg et al., Arzneim. Forsch. 34, 1736– 1738(1984). References Flower, R.J. et al (1976) Br. J. Pharmac. 56, 229– 233. Greaves, M.W. et al (1974) Br. J. Pharmac. 90, 289– 292. Lewis, R.A. et al (1982) J. Immunol. 129, 1627– 1631. References Haworth, D. and Carey, F. (1985) Prostaglandins. In Press. References Brodde, O.-E. et al. (1983). Br. J. Pharmac., 78, 72P. Limas, C. & Limas, C.J. (1978). Biochem. Biophys. Res. Commun., 83, 710– 714. McAllister, R.G. et al. (1979). Arch. Intern. Med., 139, 879– 881. Metzler, C.M. et al. (1974). Biometrics, 30, 562. Middeke, M. et al. (1983). Res. Exp. Med., 183, 227– 232. Salomon, Y. et al. (1974). Anal. Biochem., 58, 541– 548. References Camp R.D.R. et al. Prostaglandins 23: 431. (1983). Dowd P.M. et al. J. Invest. Dermatol. 84: 537. (1985). Turner S.R. et al. Nature 257: 680. (1975). Woollard P.M. J. Invest. Dermatol. 84: 455. (1985). References Aishita, H. et al. (1982) Ensho 2, 465– 466. Aishita, H. et al. (1983) Arch. Int. Pharmacodyn. Ther. 261, 316– 327. Milton, A.S. (1982) Handb. Exp. Pharmac. 60, 257– 303. References Bennett, A., Tacca, Del M. et al (1977) Br. J. Cancer, 35, 881– 884. Carter, C.A., Mulholland, R.J. et al (1983) Cancer Res. 43, 3559– 3562. Coker, S.J., Clarke, B. & Zeitlin, I.J. (1982) J. Pharmac. Method, 7, 207– 217. References Coleman, R.A., Humphrey, P.P.A., Kennedy, I., Levy, G.P. & Lumley, P. (1981). Br. J. Pharmac., 73, 773– 778. Hamid, S. & Whittle, B.J.R. (1985). Br. J. Pharmac., 85, 285– 290. MacIntyre, D.E. & Gordon, J.L. (1977). Thromb. Res., 11, 705– 713. Patscheke, H. & Stegmeier, K. (1984). Thromb. Res., 33, 277– 288. Venton, D.L., Enke, S.E. & Le Breton, G.C. (1979). J. Medicinal Chem., 22, 824– 830. Whittle, B.J.R., Moncada, S. & Vane, J.R. (1978). Prostaglandins, 16, 373– 387. References Ashton, C.H. and Stepney, R. (1982) Smoking: Psychology and Pharmacology. Tavistock, London. Golding, J.F. and Mangan, G.L. (1982) Psychophysiol. 19, 449– 456. Herning, R.T. et al., (1983) Psychophysiol. 20, 507– 512. Mangan, L. and Golding, J.F. (1984) Psychopharmacology of Smoking. Cambridge University Press, Cambridge. References Dunlop, L.S. and Smith, A.P. (1975) Br. J. Pharmac. 54. 495. Jessup, C.L. et al (1985) Proc. Br. J. Pharmac., Edinburgh. Konzett, H. and Rossler, R. (1940). Arch. Exp. Pathol. Pharmak. 195, 71. References Krall, J.F., Connelly, M., Weisbart, R. and Tuck, M.L. (1981) J. Endocrinol. Metab., 52(5), 863– 867. Doyle, V., O'Malley, K. and Kelly, J.G. (1982) J. Cardiovasc. Pharmac., 4, 738– 740. Feldman, R.D., Limbird, L.E., Nadau, J., Robertson, D. and Wood, A.J.J. (1984) N. Eng. J. Med., 310(13), 815– 819. Coleman, R.A., Humphrey, P.P.A., Kennedy, I. and Lumley, P. (1984) Trend. Pharmac Sci., 5(7), 303– 306. References Darius et al. (1984) Biomed. Biochim. Acta 43, 269. Schrör et al. (1981) Thromb. Res. 23, 59. References Smith, G.M. and Freuler, F. (1973) Bibl. Anat 12: 229– 234. Mallarkey, G. and Smith, G.M. (1985) Br. J. Pharmac. 84: 425– 430. Mallarkey, G., Motion, M.C. and Smith, G.M. (1984) Br. J. Pharmac. 83 439P. References Blackwell, G.J. et al. (1975) Biochem. Biophys. Acta 398, 178. Davis, E. et al. (1984) Br. J. Pharmac. 43, 440P. McNamee, P.M. et al. (1985) Br. J. Pharmac. In Press. Remmer, H. et al. (1967) Methods in Enzymology 10, 703. Sturton, R.L. et al. (1984) Prostaglandins 28, 652. References Berridge, M.J. et al (1982) Biochem. J. 206, 587– 595. Godfrey, P.P. et al (1985) Br. J. Pharmac. 84, 112P. Grahame-Smith, D.G. & Green, A.R. (1974) Br. J. Pharmac. 52, 19– 26. Kendall, D.A. & Nahorski, S.R. (1985) J. Pharmac. Exp. Ther. 233, 473– 479. Minchin, M.C.W. (1985) in Neuropharmacology of Serotonin, ed. A.R. Green, 117– 130, Oxford, Oxford University Press. Sherman, W.R. et al (1981) J. Neurochem. 36, 1947– 1951. References Bucala, R. et al. (1983) Science 220: 965– 967. Castro, O. et al. (1984) Am. J. Haematol. 16: 15– 21. Lowe, K.C. (1984a) Pharm. J. 232: 73– 74/78. Lowe, K.C. (1984b) Clin. Res. Rev. 4: 126– 129. Lowe, K.C. et al. (1984) Brit. J. Pharmacol. 82: 276P. Lowe, K.C. & Bollands, A.D. (1985) Med. Lab. Sci. (in press). Shah, K.H. et al. (1984) Lab. Invest. 48: 62A. Wake, E.J. et al. (1985) Transfusion 25: 73– 77. References Bright J. E. and Marrs T. C. (1982) Arch Toxicol 50 57. Calabrese E. J. (1983) Principles of Animal Extrapolation. John Wiley, New York. Klimmek R. et al (1983) Arch Toxicol 53 275. References Campbell, I.L. & Das, A.K. (1982) Biochem. Soc. Trans. 10, 392. Connelly, D.M. & Taberner, P.V. (1985) Diabetic Medicine In Press. Connelly, D.M. et al. (1983) Biochem. Pharmac. 32, 221. Herbert, V. et al. (1965) J. Clin. Endocrinol. Metab. 25, 1375. References Kirby, M.J., Pleece, S.A., Redfern, P.H. (1983). Br. J. Pharm. 80 450P. Kirby, M.J., Turner, P. (1975). Postgrad. med. J. 51 (suppl.) 73– 76. Kirby, M.J., Turner, P. (1977) Arch. Int. Pharmacodyn. Ther. 225: 25– 28. Kirby, M.J., Williams, J. (1978). Abstracts 7th International Congress in Pharmacology, p. 268. References Miyake, T. et al (1980) Dig. Dis. Sci. 25, 1. Harrington, S.J. et al (1981) J. Clin. Gastroent. 3 (2), 129– 134. References Bosanquet, A.G. and Gilby, E.D. (1984) Cancer Chemother. Pharmacol. 12, 183– 186. Goldenberg, G.J. et al. (1979) J. Biol. Chem. 254, 1057– 1065. Okada, Y. et al. (1975) Biochimica et Biophysica Acta, 413, 104– 115. Ussing, H.H. and Zerahn, K. (1951) Acta Physiol. Scand. 214, 110– 127. References Gillespie, J.S. (1972) Br. J. Pharmac. 45, 404. References Allen, A. et al (1984) Scand. J. Gastro. 19: 101– 114. Allen, A. and Garner, A. (1980) Gut 21: 249– 262. Dettmar, P.W. et al, B.S.G. Sept. 1985. Pearson, J.P. et al (1985) Gut, In Press. References Abboud, H.E. et al. (1982). J Clin Invest. 69, 327– 336. Blakemore, R.C. et al. (1981). Brit J Pharmacol. 74, 200P. Chansel D. et al (1982). Biochem Pharmacol. 31, 367– 375. Schwertschlag U. & Hackenthal E. (1982). NS Arch Pharmacol. 319, 239– 242. Williams, B.C. et al. (1983). J Hypertension 1 (Suppl 2), 177– 179. References Main, I.H.M. & Pearce, J.B. (1978) J. Pharmac. Methods 1, 27. Main, I.H.M. & Wilson, G.A.M. (1985) Br. J. Pharmac. 85. Seamon, K.B. & Daly, J.W. (1983) TIPS 4, 120. Waldeck, B. & Widmark, E. (1985) Eur. J. Pharmac. 112, 349. References Pazos, A., Hoyer, D. and Palacios, J.M. (1985). Eur. J. Pharmacol. 106: 539– 546. Nelson, D.L., Schnellmann, R. and Smit, M. (1983). Molecular Pharmacology of Neurotransmitter Receptors. ed. T. Segawa et al., Baven Press pp. 103– 114. Leysen, J.E. et al (1981) Mol. Pharmacol. 21: 301– 314. Nickolson, V.J. and Wieringa, J.M. (1981) J. Pharm. Pharmac. 33: 760– 766. References Porsolt R. et al. (1977) Arch. Int. Pharmacodyn. Ther. 229, 327– 336. Steru L. et al. (1985) Psychopharmacology 85, 367– 370. References Apperley, E. & Humphrey, P.P.A. (1977). Br. J. Pharmac., 61, 465P. Apperley et al. (1980). Br. J. Pharmac., 68, 215. Feniuk et al. (1985). Br. J. Pharmac., 86, 697. Leysen et al. (1981). Life Sci., 28, 1015. References Arunlakshana, O. & Schild, H.O. (1959) Br. J. Pharmac., 14, 48– 58. Cocks, T.M. & Angus, J.A. (1983) Nature, 305, 627– 629. Humphrey, P.P.A. (1984) Neuropharmacology, 23, 1503– 1510. Müller-Schweinitzer, E. & Engel, G. (1983) Naunyn-Schmiederberg's Arch. Pharmacol., 324, 287– 292. Saxena, P.R. & Verdouw, P.D. (1985) Br. J. Pharmac., 84, 533– 544. References Pederson, Lederballe O., Christensen, C.K., Mikkelson, E. and Ramsch, K.D. (1980) Eur. J. CIin. Pharmacol. 18: 287– 293. Lynch, P., Dargie, H., Krikler, S. and Krikler, D. (1980) Br. Med. J. 281: 184– 187. References Bruyn (1968) In: P.J. Vinken and G.W. Bruyn (Eds) Handbook of Clinical Neurology, Vol. 6 Elsevier/North Holland, Amsterdam, 298– 378. Dawbarn et al (1985) Brain Res. 340, 251– 260. Emson et al (1980) Brain Res. 199, 147– 160. References Marsden, C.A. (1984) Measurement of neurotransmitter release in vivo. Methods in the neurosciences vol. 6, Wiley, Chichester. Mueller, K. et al (1985) Brain Research 335, 231– 235. O'Neill, R.D. et al (1984) Neuroscience Letters 45, 39– 49. References Armah, I.B. & Cohnen, E. (1982) Naunyn Schmiedeb. Arch. Pharm. 319, R67. Hjorth, S. et al (1981) Psychopharmacol. Bull. 17, 180. Hoyer et al (1985) Eur. J. Pharmacol. In Press. Fozard, J.R. & Kilbinger, H. (1985) Br. J. Pharmac. In Press. Fozard, J.R. & McDermott, I. (1985) Br. J. Pharmac. 84, 69P. References Drew, G.M. et al (1979) Br. J. Pharmac. 67, 133. Heal, D.J. et al (1981) Eur. J. Pharmac. 75, 231. Kostowski, W. et al (1981) Psychopharmacology 73, 261. Nahorski, S.R. & Willcocks, A.L. (1983) Br. J. Pharmac. 78, 107P. References Brunel, S. & de Montigny, C. (1980) Soc. Neurosci. Abstr. 6, 833. Mason, R. (1984) J.Physiol. 357, 13P. Wehr, T. A., Sack, D., Rosenthal, N., Duncan, W. & Gillin, J.-C. (1983) Fed. Proc. 42, 2809– 2814. References Bizière, K. et al. (1982) Arzn. Forsch. 32, 824– 831. Bizière, K. et al. (1984) Br. J. Pharmacol. 81 Suppl, 51P. Kahn, K. (1972) Neurrol. 22, 510– 515. Passeri, M. et al. (1985) Lancet i, 824. Paysan, H.M. and Conrard J.R. (1977) Stroke 8, 194– 196. References Colquhoun, D. & Sakmann, B. (1985) J. Physiol. 369: 501– 557. Ogden, D.C. (1985) J. Physiol. 365, 77P. Ogden, D.C. & Colquhoun, D. (1985) Proc R. Soc. B225: 329– 355. Sakmann, B., Patlak, J. & Neher, E. (1980) Nature Lond. 286, 71– 73. References Korner, M. et al (1982) J. Biol. Chem. 253, 2984. Severne, Y. et al (1985) Biochem. Pharm. 34, 1611. Vauquelin, G. & Maguire, M.E. (1980) Mol. Pharm. 18, 362. References Schömig, A. et al (1984) Circ Res. 55, 689– 701. Dart A.M. & Riemersma R.A. (1985) J. Cardiovasc. Pharmacol. 7 (Suppl 5), 45– 49. References Cheng, Y.C. & Prusoff, W.H. (1973) Biochem. Pharmacol. 22, 3099– 3108. Kunos, G. et al (1980) Br. J. Pharmacol. 71, 371– 386. Ogg, G.D. et al (1985) Br. J. Pharmacol 84, Proc. Supp., P161. Stone, W.J. & Walle, T. (1980) Clin. Pharmacol. Ther. 27, 288. Walle, T. & Gaffney, T.E. (1972) J. Pharmacol. Exp. Ther. 182, 83– 92. Walle, T. et al (1979) Clin. Pharmacol. Ther. 26, 548– 554. References Babany, G. et al. (1985). Biochem. Pharmac. 34, 311. Desmond, P.V. et al. (1980). Life Sci. 26, 1261. Omura, T. & Sato, R. (1964). Biol. Chem. 239, 2370. References Barwell, C.J. (1985) Brit. J. Pharmacol. (in press). Barwell, C.J., Basma, A.N. & Keysell, G. (1984) J. Pharm. Pharmacol. 36, Proc. Suppl., 29P. Fowler, C.J., Oreland, L. & Callingham, B.A. (1981) J. Pharm. Pharmacol. 33, 341– 347. Squires, R.F. (1972) Advances in Biochem. Psyctopharmacol. 5, 355– 370. References Conney, A.H. (1967) Pharmacol. Rev. 19, 317– 366. References Burnstock, G., Evans, B., Gannon, B.J., Heath, J.W. & James V. (1971) Br. J. Pharmac., 43, 295– 301. Finberg, J.P.M., Tenne, M. and Youdim, M.B.H. (1981) Br. J. Pharmac., 73, 65– 74. Knoll, J. (1978) J. Neural Transmission, 43, 177– 198. References Child, K.J. et al. (1971) Brit. J. Anaesth., 43, 2– 13. Gyermek, L. et al. (1968) J. Med. Chem., 11, 117– 125. Harrison, N.L., & Simmonds, M.A. (1984) Brain Res., 323, 287– 292. Selye, H. (1941) Proc. Soc. Exp. Biol., 46, 116– 121. Selye, H. (1942) Endocrinology, 30, 437– 453. Simmonds, M.A. (1980) Neuropharmacology, 19, 39– 45. References Bowery, N.G. et al (1980) Nature 283, 92– 94. Molyneux, S.G. & Clarke, E.E. (1985) Clin. Chem. (in press). Schlicker, E. et al (1984) N.S. Arch. Pharmac. 326, 99– 105. References Chambon, J.P. et al (1985) Proc. Nat. Acad. Sci. USA 82, 1832– 1836. References Arbilla, S. et al (1985) N. S. Arch. Pharmacol., (in press). Langer, S.Z. et al (1985) J. Neurochem., 44 suppl. S179. Mao, C.C. et al (1975) N. S. Arch. Pharmacol., 289: 369– 378. Nicholson, A.N. & Pascoe, D.A. (1985) Br. J. Pharmacol. (in press). References Arbilla, S. et al (1985) N.S. Arch. Pharmacol. (in press). Gonon, F. et al (1983) Brain Res., 273: 207– 216. Herman, J.P. et al (1982) Life Sci., 30: 2207– 2214. Langer, S.Z. et al (1985) J. Neurochem. 44 Suppl. S179. Lavielle, S. et al (1978) Brain Res., 168: 585– 594. Thierry, A.M. et al (1976) Nature, 263: 242– 244. Zivkovic, B. et al (1985) Abs. Soc. Neurosci. Dallas, Oct. 1985. References Addae, J.I. & Stone, T.W. (1985a). Br. J. Pharmac. 84, Proc. Suppl. 91P. Addae, J.I. & Stone, T.W. (1985b). Br. J. Pharmac. 85, Proc. Suppl. 361P. Harrison, N.L. (1985). J. Physiol. 360, 381P. Ishida, A.T. & Neyton, J. (1985). Proc. Natl. Acad. USA 82, 1837– 1841. Teichberg, V.L., Tal, N., Goldberg, D. & Luini, A. (1984). Brain Res. 291, 285– 292. References Anis, N.A. et al. (1983). Br. J. Pharmac. 79, 565– 575. Berry, S.C. and Lodge, D. (1985). J.Physiol. (Lond)., 364, 34P. Evans, R.H. and Watkins, J.C. (1978). Europ. J. Pharmacol., 50, 123– 129. Evans, R.H. et al. (1982). Br. J. Pharmac., 75, 65– 75. Harrison, N.L. and Simmonds, M.A. (1985). Br. J. Pharmac. 84, 381– 391. References Collins, J.F. et al. (1984) Neurosci. Lett. 51, 371– 376. Connick, J.H. and Stone, T.W. (1985) Brit. J. Pharmac. 85, 373P. Lowry, O.H. et al. (1951) J. biol. chem. 193, 265– 275. Stone, T.W. and Collins, J.F. (1985) J. Pharm. Pharmac., In Press. Turnell, D.C. and Cooper, J.D.H. (1982) Clin. Chem. 28, 527– 531. Turski, L. et al. (1985) Brain Res. 336, 162– 166. References Carter, C.J. (1984) J. Neurol. Sci. 66, 27. Cross, A.J. et al (1985) Edinburgh Meeting. McBean, G.J. & Roberts, P.J. (1985) J. Neurochem. 44, 247. References Pickel, V.M. et al (1974) J. Comp. Neurol 155, 15– 42. Segal, M. & Bloom, F.E. (1974) a. Brain Res. 72, 79– 98. Segal, M. & Bloom, F.E. (1974) b. Brain Res. 72, 99– 114. References Fagg, G.E. and Matus, A. (1984) Proc. Nat. Acad. Sci., 81, 6876– 6880. Foster, A.C. and Fagg, G.E. (1984) Brain Res. Rev., 7, 103– 164. Julliard, K.H. and Gautheron, D.C. (1973) FEBS Lett., 37, 10– 16. Michaelis, E.K. et al., (1983) J. Neurochem., 40, 1742– 1753. Watkins, J.C. and Evand, R.H. (1981) Ann. Rev. Pharmacol. Toxicol., 21, 165– 204. References Evans, R.H. and Watkins, J.C. (1978). Eur. J. Pharmac. 50, 123– 129. Harrison, N.L. and Simmonds, M.A. (1985). Br. J. Pharmac. 84, 381– 391. References Iorio, L.C., Barnett, A., Leitz, F.M., Houser, V.P. and Korduba, C.A. (1983). J. Pharmacol. Exp. Ther. 266, 462– 468. Kebabian, J. and Calne, D.B. (1979). Nature, 277, 93– 96. Pinnock, R.D. (1983). Eur. J. Pharmac. 96, 269– 276. Pinnock, R.D. (1984). Br. J. Pharmac. 81, 631– 636. References Billard, W. et al. (1984) Life Sci., 35, 1885. O'Boyle, K.M. (1985) Br. J. Pharmacol., In Press. Pimoule, C. et al. (1985), Eur. J. Pharmacol. In Press. Shikuya, M. (1979) J. Neural Transmiss. 44, 287. References Chivers et al (1984) J. Pharm. Pharmacol. 36, 484. References Hong, M. et al (1985) Br. J. Pharmac. 84, 129P. Reches, A. et al (1983) J. Pharmac. Exp. Therap. 225, 515. References Bowyer, J.F. et al (1984) J. Pharm. Exp. Ther. 229, 671. Chesselet, M.-F. (1984) Neuroscience 12, 347. Herdon, H. et al (1985a) Br. J. Pharmac. 84, 170P. Herdon, H. et al (1985b) Brain Res. (in press). Nahorski, S.R. & Strupish, J. (1985) Br. J. Pharmac. 84, 109P. van der Zee et al (1980) Eur. J. Med. Chem. 15, 363. References Gilna, P. and Martin, F. (1983) Br. J. Pharmac. 76, 687P. References Akopyan, A.R., Bocharova, L.S. & Chemeris, N.K. (1980) Comp. Biochem. Physiol. 67C, 211– 214. Bokisch, A.J. (1984) Ph.D. Thesis University of Southampton. Chesnoy-Marchais, D. & Ascher, P. (1983) Brain Res. 259, 57– 67. Kerkut, G.A., Horn, N. & Walker, R.J. (1969) Comp. Biochem. Physiol. 30, 1061– 1074. Kerkut, G.A., Lambert, J.D.C., Gayton, R.J., Loker, J.E. & Walker, R.J. (1975) Comp. Biochem. Physiol. 50A, 1– 25. Nathanson, J.A. & Greengard, P. (1973) Science, 180, 308– 310. Osborne, N.N. (1977) Experientia, 33, 917– 919. References Blackburn, T.P., Borkowski, K.R., and Friend, J. (1985) Br. J. Pharmacol, 85, 382P. Leander, J.D. (1983) J. Pharmacol Exp. Ther. 227, 35– 41. Miller, M. (1980) J. Pharmacol Exp. Ther. 214, 608– 613. Puri, V.N. (1980) Ind. J. Exp. Biol. 18, 1185– 1186. Puri, V.N. and Sur, R.N. (1985) Acta Pharmacol. et toxicol. 56, 91– 93. References Blume, A.J. (1978). Proc. Natl. Acad. Sci. USA 75: 1713– 1717. Frey, E.A., and Kebabian, J.W. (1985) Endocrinol. 115: 1797– 1804. Motulsky, H.J., and Insel, P.A. (1983) J. Biol. Chem. 258: 3913– 3919. Werling, L.L., Zarr, G.D., Brown, S.R. and Cox, B.M. (1985) J. Pharmacol. Exp. Ther. 233: 722– 728. References Leander, J.D. (1983) J. Pharmac. Exp. Ther., 227, 35– 41. Martin, W.R. et al (1976) J. Pharmac. Exp. Ther., 197, 517– 532. Zukin, R.S. & Zukin, S.R. (1981) Molec. Pharmac., 20, 246– 250. References H.O.J. Collier, N.J. Cuthbert & D.L. Francis (1981). Br. J. Pharmacol 73, pp 921– 932. References Barbaccia, M.L. et al (1980) Pharmac. Biochem. Behav. 13, 303– 306. Chesselet, M.F. et al (1983) Brain Res. 258, 229– 242. Ducobu, J. (1984) Ann. Intern. Med. 100, 617– 618. Holman, R.B. and Snape, B.M. (1985) J. Neurochem. 44, 357– 363. Mefford, I. (1980) J. Neurosci. Methods 3, 207– 224. References Ashida, Y. et al (1983) Prostaglandins 26, 955. Cashin, C.H. et al (1979) Agents and Actions 9, 553. Gualde, N. et al (1985) J. Immunol. 134, 1125. References Finn, P.W. et al (1984) Int. J. Pept. Prot. Res. 24, 407. Griffiths, E.C. et al (1985) Regul. Pept. 10, 145. Szirtes, T. et al (1984) J. Med. Chem. 27, 741. Widdowson, P. et al (1983) Regul. Pept. 7, 357. References Dey, R.D., Shannon, W.A. & Said, S.I. (1981) Cell Tissue Res. 220, pp 231– 238. Leroux, P., Vaudry, H., Fournier, A., St. Pierre, S. & Pelletier, G. (1984) Endocrinol. 114, pp 1506– 1512. Said, S.I. (1984) Peptides 5, pp 143– 150. References Gibson, A., Bern, H.A., Ginsburg, M., & Botting, J.H. (1984) Proc. Natl. Acad. Sci. USA, 81, 625– 629. Gillespie, J.S., MacLaren, A. & Pollock, D. (1970) Br. J. Pharmac. 40, 257– 267. Lederis, K. (1984) Frontiers in Neuroendocrinology 8, 247– 263. Pearson, D., Shively, J.E., Clark, B.R., Geschwind, I.I., Barkley, M., Nishioka, R.S., & Bern, H.A. (1980) Proc. Natl. Acad. Sci. USA, 77, 5021– 5024. References Ohlstein, E.H. & Berkowitz, B.A. (1985) Hypertension, 7, 306– 310. Rapoport, R.M. & Murad, F. (1983) Circ. Res., 52, 352– 357. Schultz, K.D. et al (1977) Nature, 265, 750– 751. Winquist, R.J. et al (1984) Eur. J. Pharmac., 102, 169– 173. References Behman, B.A. & Deber, C.M. (1984) J. Biol. Chem. 259, 14935. Finn, P.W. et al (1984) Int. J. Pept. Prot. Res. 24, 407. Isogai, Y. et al (1977) Proc. Nat. Acad. Sci. USA 74, 414. Kosterlitz, H.W. (1985) Proc. R. Soc. Lond. B225, 27. Smith, C.D. & Griffin, J.F. (1978) Science 199, 1214. References Bowers, C.Y. et al (1975) In: W.E. Stumpf & L.D. Grant (eds) Anatomical Neuroendocrinology, pp 333– 342, Karger, Basel. Linton, E.A. et al (1981) J. Endocr. 90, 315– 322. Maeda, K. & Frohman, L.A. (1978) Endocrinology 103, 1903– 1909. Tuominen, R.K. et al (1983) Acta Endocrinologyica 103, 88– 94. Yeo, T. et al (1980) Br. J. clin. Pharmac. 10, 171– 173. References White B.A. and Bancroft F.C. (1982). J. Biol. Chem. 257, 8569– 8572. References Vik-Mo et al., (1974), Scand. J. Haematol., 19, 68. Handin et al., (1978), J. Lab. Clin. Med., 91, 340. Vik-Mo et al., (1978), J. Haematol., 21, 225. Ohlendorf et al., (1980) Thromb. Res., 19, 447. Smith et al., (1980), Can. J. Physiol. Pharmacol., 58, 294. Smith and Freuler (1973), Bibl. Anat., 12, 229. References Alousi, A.A. et al (1983). J. Cardiovasc. Pharmac., 5, 792. Collis, M.G. (1983). Br. J. Pharmac., 78, 207. Gristwood, R.W. et al (1985). Br. J. Pharmac., 85, 224P. References Hedner T. et al. (1984). Eur. J. Resp. Dis. 65, 153– 156. McQueen D.S. and Ribeiro J.A. (1981). Br. J. Pharmac. 74, 129– 136. Newby A.C. (1984). Trends Biochem. Sci. 9, 42– 44. Watt A.H. and Routledge P.A. (1985). Br. J. clin. Pharmac. (in press). Wessberg P. et al. (1985). Eur. J. Pharmac. 106, 59– 67. References Kaiser, Von J. et al. (1980) Arzneim. Forsch. 30, 420– 427. Kaiser; Von J. et al. (1980) Arzneim. Forsch. 30, 427– 432. References Ginsborg, B.L. & Hirst, G.D.S. (1972) J. Physiol., Lond. 224, 629– 645. Ribeiro, J.A. (1978) Life Sciences 22, 1373– 1380. Stone, T.W. (1981) Neuroscience 6, 523– 555. References Ginsborg, B.L. & Hirst, G.D.S. (1972) J. Physiol., 224, 629. Ribeiro, J.A. & Sebastião, A.M. (1985) Br. J. Pharmac., 84, 911. Ribeiro, J.A. & Walker, J. (1975) Br. J. Pharmac., 54, 213. References Foster, H. et al (1978) Br. J. Pharmac. 63, 309– 314. Foster, H. et al (1983) Br. J. Pharmac. 79, 273– 278. Moody, C.J. and Burnstock, G. (1982) Eur. J. Pharmac. 77, 1– 9. Spedding, M. and Weetman, D.F. (1976) Br. J. Pharmac. 57, 305– 310. References Buchheit, K.H. et al (1985) J. Pharm. Pharmac. In Press. References Brown, M.J. & Harland, D. (1984) Br. J. Pharmac. 83, 657. Majewski, H. et al (1983a) J. Cardiovasc. Pharmac. 5, 703. Majewski, M. et al (1983b) Eur. J. Pharmac. 93, 255. References Daum, P.R. et al (1982) Br. J. Pharmac. 77, 347– 357. Hoefke, W. & Gaida, W. (1984) IUPHAR 9TH. Internat. Congr. Pharmac. Abstr. 1704P. Hoefke, W. et al (1984) N.S. Arch. Pharmac. 325, R54. Palluk, R. et al (1985) N.S. Arch. Pharmac. 329, R79. References Cavero et al (1985) Pharmacologist (in press). Timmermans et al (1985) Naunyn-Schmied Arch Pharmacol 329: 404– 413. References Aubry et al (1985) J Cardiovasc Pharmacol 7 Suppl 6 S93– S102. Cavero et al (1984) Br J Pharmacol 81 13P. Sheridan et al (1980) J Clin Invest 65: 161– 171. References Berridge, T.L. et al (1983). Br. J. Pharmac., 78, 507– 515. Chapleo, C.B. et al (1984). J. Med. Chem., 27, 570– 576. Doxey, J.C. et al (1983). Br. J. Pharmac., 78, 489– 505. Doxey, J.C. et al (1984). Br. J. Pharmac., 81, Proc. Suppl. 181P. Joly, G. et al (1984). Arch. Int. Pharmacodyn., 269, 277– 286. References Van Meel, J.C.A. et al (1981) J. Pharmac. exp. Ther. 219, 760. References Beckeringh, J.J. et al., (1984) J. Pharmacol. Exp. Ther. 229, 515. Digges, K.V. & Summers, R.J. (1983) European J. Pharmacol. 96, 85. Dashwood, M. & Jacobs, M. (1985) European J. Pharmacol, (in press). Furchgott, R.F. & Zawadzki, J.V. (1980) Nature 288, 373. Godfraind et al., (1985) Clinical Science 68 (Suppl 10), 655. Scarborough, N.L. & Carrier, G.O. (1984) J. Pharmacol. Exp. Ther. 231, 597. References Nedergaard, O.A. (1980) J. Cardiovasc. Pharmac. 2, 629– 643. Schrold, J. & Nedergaard, O.A. (1977) Acta Physiol. Scand. 89, 129– 143. References Allaker, R.P. et al (1985) J. Dent. Res. 64, 147 Abs. Gilmour, M.N. et al (1975) J. Dent. Res. 54, 299. Greenman, J. et al (1983) J. Dent. Res. 62, 110 Abs. Singer, R.E. et al (1980) J. Dent. Res. 59, 670 Abs. Vane, J.R. (1957) Br. J. Pharmac. 12, 344. References Chand, N. and Altura, B.M. (1981) Science 213: 1376– 1379. Furchgott, R.F. (1984) Ann Rev Pharmacol Toxicol 24: 175– 197. Hamasaki, Y., Mojarad, M. and Said, S.I. (1983) J Appl Physiol 54: 1607– 1611. References Brodde, O.-E. et al. (1978) J. Mol. Cell. Cardiol. 10, 207– 219. Brodde, O.-E. et al. (1983) Circ. Res. 53, 752– 758. Brodde, O.-E. et al. (1984) J. Cardiovasc. Pharmacol. 6, 1184– 1191. Gilman, A.G. (1970) Proc. Natl. Acad. Sci. USA 67, 305– 312. Stiles, G.L. et al. (1983) Life Sci. 33, 467– 473. Sutherland, E.W. et al. (1968) Circulation 37, 279– 306. Waelbroeck, M. et al. (1983) Molec. Pharmacol. 24, 174– 182. References Holt, S.E., Cooper, M. & Wyllie, J.H. (1985), Eur. J. Pharmac. (in press). References Bretag, A.H. (1969). Life Sciences 8, 319– 329. Crandall et al. (1982). Toxicol. Appl. Pharmacol. 62, 152– 157. Gudbjarnason, S. & Hallgrimsson, J. (1979) in Ischaemic Myocardium and Antianginal Drugs. edit. M.M. Winburg and Y. Abiko, Raven Press, New York. Logan, R.L. et al. (1977). Atherosclerosis 27, 265– 269. Selye, H. et al. (1960). Angiology 11, 398– 407. Stubbs, C.D. & Smith, A.D. (1984). Biochem. Biophys. Acta 779, 89– 137. References Chidsey, C.A. et al (1965). Am. J. Med. 39, 442– 451. Gristwood, R.W. and Owen, D.A.A. (1983). Br. J. Pharmac. 78, 30P. References Lenton, E.A. (1984) Clin. Endocrinol. 20, 129. Schreiber, J.R. et al (1980) Mol. Cell. Endocrinol. 19, 165. Uilenbroek, J.T.J. et al (1983) J. Endocrinol. 99, 469. References Aberg, G. (1972). Acta Pharmacol et Toxicol 31, 46P. Aberg, G. & Wahlstrom, B. (1972). Acta Pharmacol et Toxicol 31, 255– 266. Aps, C. & Reynolds, F. (1976). Br J Anaesth 48, 1171– 1174. Campbell, J.K., Marshall, R.J. & Winlow, E. (1983). Eur J Pharmacol 86, 217– 228. Cheung, D.W. (1985). Br J Pharmac 85, 317– 319. Docherty, J.R. & Hyland, L. (1985). Br J Pharmac 84, 573– 576. References Benham, C. & Bolton, T.B. (1983) Br. J. Pharmac. 80, 409– 420. Bolton, T.B., Clark, J.P., Kitamura, K. & Lang, R.J. (1981) J. Physiol. 320, 363– 379. References Berne, R.M., Herlihy, J.T., Schrader, J. and Rubio, R. (1976) In Ionic actions on vascular smooth muscle. ed E. Betz. Springer-Verlag, Berlin pp 137– 140. DeMey, J.G. and Vanhoutte, P.M. (1981) J. Physiol. 316, 347– 355. Deussen, A., Moser, G. and Schrader, J. (1985) In Purines: Pharmacology and Physiological Roles. ed. T.W. Stone Macmillan, London, p. 259. Long, C.J. and Stone, T.W. (1985a) Br. J. Pharm. 84, 152P. Long, C.J. and Stone, T.W. (1985b) Blood Vessels. In Press. References Chan, R. et al (1983) Dig. Dis & Sci, 28, 609– 615. Wan, B.Y.C. & Gottfried, S. (1985). J. Pharm. Pharmacol (in press). References Kaymakcalan, S. (1979) in Marihuana Biological Effects. Ed G.G. Nahas & W.D.M. Paton, 591. Razdan, R.K. & Howes, J.F. (1983) Med. Res. Revs 3, 119. Smith, C.G. (1980) NIDA Research Monographs 31, 120. References Soares-Da-Silva, P. & Davidson, R. (1985) Naunyn-Schmiedeberg's Arch Pharmacol. 329, 253– 257. Caramona, M.M. & Soares-Da-Silva, P. (1985) Br. J. Pharmac. In Press. References Marceau, F. et al (1981) Can. J. Physiol. Pharmac., 59, 921. Spector, W.G. et al (1958) Pharmac. Rev., 10, 475. Regoli, D. & Barabé, J. (1980) Pharmac. Rev., 32, 1. Stewart, J. & Vavrek, R.J. (1984) Proc. of Kinin ‘84 Savannah. Int. Cong. p 134. Whalley, E.T. (1985) Proc. Brit. Pharmac. Soc. Edinburgh. References Hamilton, T.C. et al (1985) Br. J. Pharmac. In Press. Inoue, T. et al (1983) Br. J. Pharmac. 80, 459. Inoue, T. et al (1984) J. Pharmac. exp. Ther. 229, 793. Itoh, T. et al (1981) J. Pharmac. exp. Ther. 218, 260. Kajiwara, M. et al (1984) J. Pharmac. exp. Ther. 230, 462. Karashima, T. et al (1982) J. Pharmac. exp. Ther. 221, 472. Maruyama, M. et al., (1982) Arch. int. Pharmacodyn. 258, 260. Weir, S.W. and Weston, A.H. (1985) J. Physiol. submitted for publication. References Ambache, N. and Zar, M.A. (1971) J. Physiol, 216, 359– 389. McGrath, J.C. (1978) J. Physiol., 283, 23– 39. References Green, A.R. (1984) Neuropharmacology 23, 1521– 1528. Humphrey, P.P.A. (1984) Neuropharmacology 23, 1503– 1510. References Benwell. M.E.M. & Balfour, D.J.K. (1982). Psychopharmacology. 76, 160– 162. Quik, M. & Azmitia, E. (1983). Eur. J. Pharmac., 90. 377– 384. Reinhard. J.F., Moskovitz, M.A., Sved, A.F. & Fernstrom, J.D. (1980). Life Sci. 27, 905– 911. References Bennett, G.W. et al (1985a) Br. J. Pharmac. 85, 244P. Bennett, G.W. et al (1985b) Br. J. Pharmac. (in press). Lighton, C. et al (1984) Neuropharmacology 23, 963– 966. Lighton, C. et al (1985) Neuropharmacology 24, 401– 406. References Alliot, J. & Alexinsky, T. (1982) Physiol. Behav. 28, 525– 530. De Wied, D. (1971) Nature (Lond.) 232, 58– 60. Ebenezer, I.S. (1985) Br. J. Pharmac. 84, 107P. Ettenberg et al (1983) Behav. Brain Res. 7, 331– 350. Silverman, P. (1978) Animal Behaviour in the Laboratory. Chapman & Hall, Lond. References Goodwin, G.M. & Green, A.R. (1985) Br. J. Pharmac. 84, 743– 753. Harrison-Read, P.E. (1978) In ‘Lithium in Medical Practice’ MTP, Lancaster. Harrison-Read, P.E. (1983a) Br. J. Pharmac. 79, Proc. Suppl., 394P. Harrison-Read, P.E. (1983b) Br. J. Pharmac. 78, Proc. Suppl., 92P. Tricklebank, M.D. et al (1984) Eur. J. Pharmac. 106, 271– 282. References Wood, P.L. (1982) Neuropharmacology 21: 487– 497. References C.K. Atterwill et al (1984) J. Neural. Transm. 59, 43. D.J. Heal et al (1981) Eur. J. Pharmacol. 75, 231. D.C. U'Prichard et al (1980) Brain Res. 180, 143. I.C. Wilson et al (1974) In: The Thyroid Axis, Drugs & Behaviour (Ed. A.J. Prange) Raven Press p. 49. I. Zebrowska-Lupina et al (1977) Naunyn-Schmiedeb. Arch. Pharmac. 297, 227. References Cook N., Nahorski SR., Barnett DB. (1985) Eur J Pharm, 113, 247– 254. Linden J., Patel A., Spanier AM., Weglicki WB. (1984) J Biol Chem, 259, 15115– 15122. References Baker SP., Boyd HM., Potter LT. 1980 Brit J Pharm, 68, 57– 63. Bristow MR. 1984 New Eng J Med, 311(13) 850– 851. References Erecińska, M., Nelson, D., Wilson, D.F. & Silver, I.A. (1984) Brain Res. 304, 9– 22. Faden, A.I. (1984) Stroke 15, 575– 578. References Gnegy, M.E. et al (1980) Ann. N.Y. Acad. Sci., 356, 304– 318. Hass, W.K. (1983) Neurologic Clinics, 1, 345– 353. Shiu, G.K. & Nemoto, E.M. (1981) J. Neurochem., 37, 1448– 1456. Siesjo, B.K. (1981) J. Cereb. Blood Flow Met., 1, 155– 185. Volume87, IssueS1March 1986Pages 95P-224P ReferencesRelatedInformation
Referência(s)